Butanoic acid,2-hydroxy-2-[1-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]ethyl]-3-methyl-,[(1S,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl ester,(2S,3S)- (9CI)
| Product Information | |
|---|---|
| Product Number: | AX-DR1I |
| Product Name: | Butanoic acid,2-hydroxy-2-[1-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]ethyl]-3-methyl-,[(1S,7aR)-2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl]methyl ester,(2S,3S)- (9CI) |
| CAS: | 120193-39-7 |
| MW: | |
| Synonyms: | Butanoicacid,2-hydroxy-2-[1-[[3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]ethyl]-3-methyl-,(2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl ester, [1S-[1a,7[2R*,3R*(E)],7aa]]-; (-)-Cynoglossamine;Cynoglossamine |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |